https://clinicaltrials.gov/ct2/show/NCT03610516?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F01%2F2019&lupd_d=14
Condition : Lupus Nephritis
Interventions : Drug: CFZ533; Drug: Placebo
Sponsor : Novartis Pharmaceuticals
Recruiting
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
NCT03610516
Wed, 01 Aug 2018 12:00:00 EDT